Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24108508 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sara Standoli und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Endocannabinoids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (MUR) under the National Operative Program (PON)-Programma Operativo Nazionale Ricerca e Innovazione 2014-2020 (CCI…, competitive grant PRIN 2017-2017BTHJ4R (to M.M.), intramural competitive grant DISCAB GRANT 07_DG_2022_12 awarded by the Department of Biotechnological and Applied Clinical Sciences - University of L'Aquila.
Abstract (Originalsprache)
Microglia, the resident immune cells of the central nervous system, play important roles in brain homeostasis as well as in neuroinflammation, neurodegeneration, neurovascular diseases, and traumatic brain injury. In this context, components of the endocannabinoid (eCB) system have been shown to shift microglia towards an anti-inflammatory activation state. Instead, much less is known about the functional role of the sphingosine kinase (SphK)/sphingosine-1-phosphate (S1P) system in microglia biology. In the present study, we addressed potential crosstalk of the eCB and the S1P systems in BV2 mouse microglia cells challenged with lipopolysaccharide (LPS). We show that URB597, the selective inhibitor of fatty acid amide hydrolase (FAAH)—the main degradative enzyme of the eCB anandamide—prevented LPS-induced production of tumor necrosis factor-α (TNFα) and interleukin-1β (IL-1β), and caused the accumulation of anandamide itself and eCB-like molecules such as oleic acid and cis-vaccenic acid ethanolamide, palmitoylethanolamide, and docosahexaenoyl ethanolamide. Furthermore, treatment with JWH133, a selective agonist of the eCB-binding cannabinoid 2 (CB2) receptor, mimicked the anti-inflammatory effects of URB597. Interestingly, LPS induced transcription of both SphK1 and SphK2, and the selective inhibitors of SphK1 (SLP7111228) and SphK2 (SLM6031434) strongly reduced LPS-induced TNFα and IL-1β production. Thus, the two SphKs were pro-inflammatory in BV2 cells in a non-redundant manner. Most importantly, the inhibition of FAAH by URB597, as well as the activation of CB2 by JWH133, prevented LPS-stimulated transcription of SphK1 and SphK2. These results present SphK1 and SphK2 at the intersection of pro-inflammatory LPS and anti-inflammatory eCB signaling, and suggest the further development of inhibitors of FAAH or SphKs for the treatment of neuroinflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioscience and Technology for Food Agriculture and Environment, University of Teramo, 64100 Teramo, Italy.
- Department of Veterinary Medicine, University of Teramo, 64100 Teramo, Italy.
- Institute of General Pharmacology and Toxicology, University Hospital Frankfurt, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
- Institute of Clinical Pharmacology, Goethe University Frankfurt, 60590 Frankfurt am Main, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Fraunhofer Cluster of Excellence for Immune Mediated Diseases (CIMD), 60596 Frankfurt am Main, Germany.
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
ORCID-Profile: Sara Standoli, Cinzia Rapino, Camilla Di Meo, Dominique Thomas, Dagmar Meyer Zu Heringdorf, Mauro Maccarrone
Förderung
- Italian Ministry of University and Research (MUR) under the National Operative Program (PON)-Programma Operativo Nazionale Ricerca e Innovazione 2014-2020 (CCI…
- competitive grant PRIN 2017-2017BTHJ4R (to M.M.)
- intramural competitive grant DISCAB GRANT 07_DG_2022_12 awarded by the Department of Biotechnological and Applied Clinical Sciences - University of L'Aquila
- Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD
- Deutsche Forschungsgemeinschaft
- Italian Ministry of University and Research (MUR)
- Fondo Sociale Europeo (FSE)
- Department of Biotechnological and Applied Clinical Sciences—University of L’Aquila
Zitieren
APA
Standoli, S., Rapino, C., Di Meo, C., Rudowski, A., Kämpfer-Kolb, N., Volk, L. M., Thomas, D., Trautmann, S., Schreiber, Y., Meyer Zu Heringdorf, D., & Maccarrone, M. (2023). Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24108508
Vancouver
Standoli S, Rapino C, Di Meo C, Rudowski A, Kämpfer-Kolb N, Volk LM, et al. Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24108508
BibTeX
@article{Standoli2023,
author = {Standoli, Sara and Rapino, Cinzia and Di Meo, Camilla and Rudowski, Agnes and Kämpfer-Kolb, Nicole and Volk, Luisa Michelle and Thomas, Dominique and Trautmann, Sandra and Schreiber, Yannick and Meyer Zu Heringdorf, Dagmar and Maccarrone, Mauro},
title = {Sphingosine Kinases at the Intersection of Pro-Inflammatory LPS and Anti-Inflammatory Endocannabinoid Signaling in BV2 Mouse Microglia Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24108508}
}
EUVIMED